Janus Henderson Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,593,352
| Closed | -$274M | – | 2631 |
|
2021
Q3 | $274M | Sell |
1,593,352
-208,470
| -12% | -$35.9M | 0.12% | 189 |
|
2021
Q2 | $226M | Sell |
1,801,822
-71,980
| -4% | -$9.03M | 0.1% | 217 |
|
2021
Q1 | $254M | Buy |
1,873,802
+59,761
| +3% | +$8.1M | 0.12% | 192 |
|
2020
Q4 | $232M | Buy |
1,814,041
+30,102
| +2% | +$3.85M | 0.11% | 196 |
|
2020
Q3 | $201M | Buy |
+1,783,939
| New | +$201M | 0.1% | 198 |
|
2020
Q1 | – | Sell |
-1,133,861
| Closed | -$60.1M | – | 1459 |
|
2019
Q4 | $60.1M | Sell |
1,133,861
-211,544
| -16% | -$11.2M | 0.03% | 528 |
|
2019
Q3 | $53.2M | Buy |
1,345,405
+35,736
| +3% | +$1.41M | 0.03% | 560 |
|
2019
Q2 | $53.8M | Sell |
1,309,669
-864
| -0.1% | -$35.5K | 0.03% | 554 |
|
2019
Q1 | $61M | Buy |
1,310,533
+34,346
| +3% | +$1.6M | 0.03% | 530 |
|
2018
Q4 | $55.6M | Sell |
1,276,187
-118,069
| -8% | -$5.14M | 0.04% | 507 |
|
2018
Q3 | $79.8M | Buy |
1,394,256
+161,049
| +13% | +$9.22M | 0.04% | 460 |
|
2018
Q2 | $59.8M | Buy |
+1,233,207
| New | +$59.8M | 0.03% | 500 |
|